129 related articles for article (PubMed ID: 37040224)
1. Delayed adverse reactions in whole blood donors: Importance of active surveillance in identifying the missing gaps in the donor safety.
Gupta AM; Bajpai M
Indian J Med Res; 2023 Jan; 157(1):30-36. PubMed ID: 37040224
[TBL] [Abstract][Full Text] [Related]
2. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
Gupta AM; Bajpai M
J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
[TBL] [Abstract][Full Text] [Related]
3. Delayed adverse reaction in donors after whole blood donation: Is it a matter of concern?
Kumar R; Kaur P; Verma K; Rajeev K; Bhaskar B; Kumar S
Transfus Clin Biol; 2023 May; 30(2):232-237. PubMed ID: 36638906
[TBL] [Abstract][Full Text] [Related]
4. Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!
Kaur S; Mittal K; Kaur R; Kaur G; Kaur P; Sood T
Transfus Clin Biol; 2022 May; 29(2):141-146. PubMed ID: 34856397
[TBL] [Abstract][Full Text] [Related]
5. Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: First attempt in India.
Tiwari AK; Aggarwal G; Dara RC; Arora D; Srivastava K; Raina V
Transfus Apher Sci; 2017 Apr; 56(2):141-146. PubMed ID: 27839968
[TBL] [Abstract][Full Text] [Related]
6. The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors.
Gupta AM; Bajpai M
J Clin Apher; 2021 Aug; 36(4):621-627. PubMed ID: 33942928
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic Factors Related to Adverse Donor Reactions in Shenzhen.
Sun LY; Yu Q; He CM; Wang SX
Int J Gen Med; 2023; 16():5493-5499. PubMed ID: 38021070
[TBL] [Abstract][Full Text] [Related]
8. Long-term poor sleep quality is associated with adverse donor reactions in college students in Central China: A population-based cross-sectional study.
Ke S; Xu P; Xiong J; Xu L; Ma M; Du X; Yang R
Vox Sang; 2023 Jun; 118(6):455-462. PubMed ID: 37191246
[TBL] [Abstract][Full Text] [Related]
9. Self-ignored onsite adverse donor reaction among whole blood donors: A single center experience from India.
Rajendran V; Paonam B; Chenna D; Mohan G; Shastry S; Jose P; Kandasamy D
Transfus Clin Biol; 2022 May; 29(2):124-128. PubMed ID: 35031508
[TBL] [Abstract][Full Text] [Related]
10. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
Py JY; Durieux S; Barnoux M; Sapey T
Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk predictors analysis of adverse donor reactions in whole blood donation.
Prakash S; Das PK; Mishra D; Ray GK; Routray S; Naik A; Mukherjee S
Transfus Clin Biol; 2020 Nov; 27(4):207-212. PubMed ID: 33027707
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects in blood donors after whole-blood donation: a study of 1000 blood donors interviewed 3 weeks after whole-blood donation.
Newman BH; Pichette S; Pichette D; Dzaka E
Transfusion; 2003 May; 43(5):598-603. PubMed ID: 12702180
[TBL] [Abstract][Full Text] [Related]
13. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
14. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
Eluwa GI; Badru T; Agu KA; Akpoigbe KJ; Chabikuli O; Hamelmann C
BMC Clin Pharmacol; 2012 Feb; 12():7. PubMed ID: 22369677
[TBL] [Abstract][Full Text] [Related]
17. Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational follow-up study.
Sendekie AK; Netere AK; Tesfaye S; Dagnew EM; Belachew EA
PLoS One; 2023; 18(2):e0282096. PubMed ID: 36827307
[TBL] [Abstract][Full Text] [Related]
18. Frequency and risk factors for donor reactions in an anonymous blood donor survey.
Goldman M; Osmond L; Yi QL; Cameron-Choi K; O'Brien SF
Transfusion; 2013 Sep; 53(9):1979-84. PubMed ID: 23228195
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
[TBL] [Abstract][Full Text] [Related]
20. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.
Qing-ping S; Xiao-dong J; Feng D; Yan L; Mei-ling Y; Jin-xiu Z; Shu-qiang Z
BMC Health Serv Res; 2014 Feb; 14():73. PubMed ID: 24533894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
